Adrian Whitty - Publications

Affiliations: 
Chemistry GRS Boston University, Boston, MA, United States 
Area:
Biochemistry, General Biophysics, Molecular Biology

56 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cate RL, di Clemente N, Racine C, Groome NP, Pepinsky RB, Whitty A. The anti-Müllerian hormone prodomain is displaced from the hormone/prodomain complex upon bivalent binding to the hormone receptor. The Journal of Biological Chemistry. 298: 101429. PMID 34801555 DOI: 10.1016/j.jbc.2021.101429  0.377
2020 Wakefield AE, Yueh C, Beglov D, Castilho MS, Kozakov D, Keserű GM, Whitty A, Vajda S. Benchmark Sets for Binding Hot Spot Identification in Fragment-Based Ligand Discovery. Journal of Chemical Information and Modeling. PMID 33291870 DOI: 10.1021/acs.jcim.0c00877  0.376
2020 Pyeatt G, Muellers S, Whitty A, Allen KN. Structural Characterization of the Covalent Binding of Keap1 and Thiol‐containing Small Molecules The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.07357  0.423
2019 Zhong M, Lynch AJ, Muellers SN, Jehle S, Luo L, Hall DR, Iwase R, Carolan JP, Egbert M, Wakefield A, Streu K, Harvey CM, Ortet PC, Kozakov D, Vajda S, ... ... Whitty A, et al. Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-associated Protein 1 (KEAP1) and Nuclear Factor, Erythroid 2 Like 2 (Nrf2). Biochemistry. PMID 31851823 DOI: 10.1021/Acs.Biochem.9B00943  0.502
2019 Yueh C, Rettenmaier J, Xia B, Hall DR, Alekseenko A, Porter KA, Barkovich K, Keseru G, Whitty A, Wells JA, Vajda S, Kozakov D. Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases. Journal of Medicinal Chemistry. PMID 31274316 DOI: 10.1021/Acs.Jmedchem.9B00089  0.361
2019 Egbert M, Whitty A, Keseru GM, Vajda S. Why some targets benefit from beyond rule of five drugs. Journal of Medicinal Chemistry. PMID 31188592 DOI: 10.1021/Acs.Jmedchem.8B01732  0.357
2019 Shaffer R, DeMaria AH, Kagermazova L, Liu Y, Babaei M, Penix S, Cervantes A, Jehle S, Makowski L, Gilmore TD, Whitty A, Allen KN. A Central Region of NEMO is Required for IKKβ-Induced Conformational Change and for Signal Propagation. Biochemistry. PMID 31145594 DOI: 10.1021/Acs.Biochem.8B01316  0.427
2018 Vajda S, Beglov D, Wakefield AE, Egbert M, Whitty A. Cryptic binding sites on proteins: definition, detection, and druggability. Current Opinion in Chemical Biology. 44: 1-8. PMID 29800865 DOI: 10.1016/J.Cbpa.2018.05.003  0.459
2018 Beglov D, Hall DR, Wakefield AE, Luo L, Allen KN, Kozakov D, Whitty A, Vajda S. Exploring the structural origins of cryptic sites on proteins. Proceedings of the National Academy of Sciences of the United States of America. PMID 29581267 DOI: 10.1073/Pnas.1711490115  0.441
2017 Mukherjee H, Debreczeni J, Breed J, Tentarelli S, Aquila B, Dowling JE, Whitty A, Grimster NP. A study of the reactivity of S((VI))-F containing warheads with nucleophilic amino-acid side chains under physiological conditions. Organic & Biomolecular Chemistry. PMID 29119993 DOI: 10.1039/C7Ob02028G  0.364
2017 Whitty A, Viarengo LA, Zhong M. Progress towards the broad use of non-peptide synthetic macrocycles in drug discovery. Organic & Biomolecular Chemistry. PMID 28876025 DOI: 10.1039/C7Ob00056A  0.364
2015 Hall DR, Kozakov D, Whitty A, Vajda S. Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery. Trends in Pharmacological Sciences. 36: 724-36. PMID 26538314 DOI: 10.1016/J.Tips.2015.08.003  0.43
2015 Vajda S, Whitty A, Kozakov D. Fragments and hot spots in drug discovery. Oncotarget. 6: 18740-1. PMID 26300051 DOI: 10.18632/Oncotarget.4968  0.49
2015 Kozakov D, Hall DR, Napoleon RL, Yueh C, Whitty A, Vajda S. New Frontiers in Druggability. Journal of Medicinal Chemistry. PMID 26230724 DOI: 10.1021/Acs.Jmedchem.5B00586  0.343
2015 Whitty A, Zhou L. Horses for courses: reaching outside drug-like chemical space for inhibitors of challenging drug targets. Future Medicinal Chemistry. 7: 1093-5. PMID 26132520 DOI: 10.4155/Fmc.15.56  0.492
2015 Kozakov D, Hall DR, Jehle S, Luo L, Ochiana SO, Jones EV, Pollastri M, Allen KN, Whitty A, Vajda S. Ligand deconstruction: Why some fragment binding positions are conserved and others are not. Proceedings of the National Academy of Sciences of the United States of America. 112: E2585-94. PMID 25918377 DOI: 10.1073/Pnas.1501567112  0.492
2015 Yeo AT, Chennamadhavuni S, Whitty A, Porco JA, Gilmore TD. Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines. Molecules (Basel, Switzerland). 20: 7474-94. PMID 25915462 DOI: 10.3390/Molecules20057474  0.346
2015 Atanasova M, Whitty A. Activation of the RET Receptor Tyrosine Kinase by Agonist Antibodies Results in Distinct Signaling Effects The Faseb Journal. 29. DOI: 10.1096/Fasebj.29.1_Supplement.728.44  0.392
2015 Kozakov D, Hall DR, Jehle S, Luo L, Ochiana SO, Jones EV, Pollastri M, Allen KN, Whitty A, Vajda S. Correction for "Ligand deconstruction: Why some fragment binding positions are conserved and others are not," Proceedings of the National Academy of Sciences of the United States of America. 112: E3749. DOI: 10.1073/pnas.1511466112  0.318
2014 Zhou L, Yeo AT, Ballarano C, Weber U, Allen KN, Gilmore TD, Whitty A. Disulfide-mediated stabilization of the IκB kinase binding domain of NF-κB essential modulator (NEMO). Biochemistry. 53: 7929-44. PMID 25400026 DOI: 10.1021/Bi500920N  0.561
2014 Villar EA, Beglov D, Chennamadhavuni S, Porco JA, Kozakov D, Vajda S, Whitty A. How proteins bind macrocycles. Nature Chemical Biology. 10: 723-31. PMID 25038790 DOI: 10.1038/Nchembio.1584  0.463
2013 Cote SM, Gilmore TD, Shaffer R, Weber U, Bollam R, Golden MS, Glover K, Herscovitch M, Ennis T, Allen KN, Whitty A. Mutation of nonessential cysteines shows that the NF-κB essential modulator forms a constitutive noncovalent dimer that binds IκB kinase-β with high affinity. Biochemistry. 52: 9141-54. PMID 24266532 DOI: 10.1021/Bi401368R  0.738
2013 Day ES, Capili AD, Borysenko CW, Zafari M, Whitty A. Determining the affinity and stoichiometry of interactions between unmodified proteins in solution using Biacore. Analytical Biochemistry. 440: 96-107. PMID 23711722 DOI: 10.1016/J.Ab.2013.05.012  0.493
2013 Golden MS, Cote SM, Sayeg M, Zerbe BS, Villar EA, Beglov D, Sazinsky SL, Georgiadis RM, Vajda S, Kozakov D, Whitty A. Comprehensive experimental and computational analysis of binding energy hot spots at the NF-κB essential modulator/IKKβ protein-protein interface. Journal of the American Chemical Society. 135: 6242-56. PMID 23506214 DOI: 10.1021/Ja400914Z  0.739
2012 Day ES, Cote SM, Whitty A. Binding efficiency of protein-protein complexes. Biochemistry. 51: 9124-36. PMID 23088250 DOI: 10.1021/Bi301039T  0.742
2012 Atanasova M, Whitty A. Understanding cytokine and growth factor receptor activation mechanisms. Critical Reviews in Biochemistry and Molecular Biology. 47: 502-30. PMID 23046381 DOI: 10.3109/10409238.2012.729561  0.357
2012 Zerbe BS, Hall DR, Vajda S, Whitty A, Kozakov D. Relationship between hot spot residues and ligand binding hot spots in protein-protein interfaces. Journal of Chemical Information and Modeling. 52: 2236-44. PMID 22770357 DOI: 10.1021/Ci300175U  0.514
2011 Kozakov D, Hall DR, Chuang GY, Cencic R, Brenke R, Grove LE, Beglov D, Pelletier J, Whitty A, Vajda S. Structural conservation of druggable hot spots in protein-protein interfaces. Proceedings of the National Academy of Sciences of the United States of America. 108: 13528-33. PMID 21808046 DOI: 10.1073/Pnas.1101835108  0.475
2011 Silvian LF, Friedman JE, Strauch K, Cachero TG, Day ES, Qian F, Cunningham B, Fung A, Sun L, Shipps GW, Su L, Zheng Z, Kumaravel G, Whitty A. Small molecule inhibition of the TNF family cytokine CD40 ligand through a subunit fracture mechanism. Acs Chemical Biology. 6: 636-47. PMID 21417339 DOI: 10.1021/Cb2000346  0.495
2010 di Clemente N, Jamin SP, Lugovskoy A, Carmillo P, Ehrenfels C, Picard JY, Whitty A, Josso N, Pepinsky RB, Cate RL. Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta. Molecular Endocrinology (Baltimore, Md.). 24: 2193-206. PMID 20861221 DOI: 10.1210/Me.2010-0273  0.451
2009 Arkin MR, Whitty A. The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions. Current Opinion in Chemical Biology. 13: 284-90. PMID 19553156 DOI: 10.1016/J.Cbpa.2009.05.125  0.38
2008 Whitty A. Cooperativity and biological complexity. Nature Chemical Biology. 4: 435-9. PMID 18641616 DOI: 10.1038/Nchembio0808-435  0.348
2008 Whitty A, Riera TV. New ways to target old receptors. Current Opinion in Chemical Biology. 12: 427-33. PMID 18570899 DOI: 10.1016/J.Cbpa.2008.05.014  0.331
2006 Schlee S, Carmillo P, Whitty A. Quantitative analysis of the activation mechanism of the multicomponent growth-factor receptor Ret. Nature Chemical Biology. 2: 636-44. PMID 17013378 DOI: 10.1038/Nchembio823  0.368
2006 Cachero TG, Schwartz IM, Qian F, Day ES, Bossen C, Ingold K, Tardivel A, Krushinskie D, Eldredge J, Silvian L, Lugovskoy A, Farrington GK, Strauch K, Schneider P, Whitty A. Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor). Biochemistry. 45: 2006-13. PMID 16475789 DOI: 10.1021/Bi051685O  0.319
2005 Carmillo P, Dagø L, Day ES, Worley DS, Rossomando A, Walus L, Orozco O, Buckley C, Miller S, Tse A, Cate RL, Rosenblad C, Sah DW, Grønborg M, Whitty A. Glial cell line-derived neurotrophic factor (GDNF) receptor alpha-1 (GFR alpha 1) is highly selective for GDNF versus artemin. Biochemistry. 44: 2545-54. PMID 15709767 DOI: 10.1021/Bi049247P  0.419
2005 Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M, Hsu YM, Whitty A. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry. 44: 1919-31. PMID 15697217 DOI: 10.1021/Bi048227K  0.493
2003 Rawat R, Whitty A, Tonge PJ. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proceedings of the National Academy of Sciences of the United States of America. 100: 13881-6. PMID 14623976 DOI: 10.1073/Pnas.2235848100  0.419
2003 Pelletier M, Thompson JS, Qian F, Bixler SA, Gong D, Cachero T, Gilbride K, Day E, Zafari M, Benjamin C, Gorelik L, Whitty A, Kalled SL, Ambrose C, Hsu YM. Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF. The Journal of Biological Chemistry. 278: 33127-33. PMID 12796483 DOI: 10.1074/Jbc.M305754200  0.325
2002 Day ES, Osborn L, Whitty A. Effect of divalent cations on the affinity and selectivity of alpha4 integrins towards the integrin ligands vascular cell adhesion molecule-1 and mucosal addressin cell adhesion molecule-1: Ca2+ activation of integrin alpha4beta1 confers a distinct ligand specificity. Cell Communication & Adhesion. 9: 205-19. PMID 12699089 DOI: 10.1080/15419060216014  0.472
2002 Bell AF, Feng Y, Hofstein HA, Parikh S, Wu J, Rudolph MJ, Kisker C, Whitty A, Tonge PJ. Stereoselectivity of enoyl-CoA hydratase results from preferential activation of one of two bound substrate conformers. Chemistry & Biology. 9: 1247-55. PMID 12445775 DOI: 10.1016/S1074-5521(02)00263-6  0.315
2002 Pepinsky RB, Mumford RA, Chen LL, Leone D, Amo SE, Riper GV, Whitty A, Dolinski B, Lobb RR, Dean DC, Chang LL, Raab CE, Si Q, Hagmann WK, Lingham RB. Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1. Biochemistry. 41: 7125-41. PMID 12033947 DOI: 10.1021/bi020024d  0.339
2001 Runkel L, De Dios C, Karpusas M, Baker D, Li Z, Zafari M, Betzenhauser M, Muldowney C, Miller S, Redlich PN, Grossberg SE, Whitty A, Hochman PS. Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 21: 931-41. PMID 11747625 DOI: 10.1089/107999001753289541  0.455
2001 Bromley SK, Iaboni A, Davis SJ, Whitty A, Green JM, Shaw AS, Weiss A, Dustin ML. The immunological synapse and CD28-CD80 interactions. Nature Immunology. 2: 1159-66. PMID 11713465 DOI: 10.1038/Ni737  0.304
2001 Ling Chen L, Whitty A, Scott D, Lee WC, Cornebise M, Adams SP, Petter RC, Lobb RR, Pepinsky RB. Evidence That Ligand and Metal Ion Binding to Integrin α 4β1 Are Regulated through a Coupled Equilibrium Journal of Biological Chemistry. 276: 36520-36529. PMID 11473127 DOI: 10.1074/Jbc.M106216200  0.412
2001 Taylor FR, Wen D, Garber EA, Carmillo AN, Baker DP, Arduini RM, Williams KP, Weinreb PH, Rayhorn P, Hronowski X, Whitty A, Day ES, Boriack-Sjodin A, Shapiro RI, Galdes A, et al. Enhanced potency of human Sonic hedgehog by hydrophobic modification Biochemistry. 40: 4359-4371. PMID 11284692 DOI: 10.1021/Bi002487U  0.379
2000 Runkel L, deDios C, Karpusas M, Betzenhauser M, Muldowney C, Zafari M, Benjamin CD, Miller S, Hochman PS, Whitty A. Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity. Biochemistry. 39: 2538-51. PMID 10704203 DOI: 10.1021/Bi991631C  0.465
1999 Majeau GR, Whitty A, Yim K, Meier W, Hochman PS. Low affinity binding of an LFA-3/IgG1 fusion protein to CD2+ T cells is independent of cell activation Cell Adhesion and Communication. 7: 267-279. PMID 10626910 DOI: 10.3109/15419069909010808  0.445
1999 Day ES, Wen D, Garber EA, Hong J, Avedissian LS, Rayhorn P, Shen W, Zeng C, Bailey VR, Reilly JO, Roden JA, Moore CB, Williams KP, Galdes A, Whitty A, et al. Zinc-dependent structural stability of human sonic hedgehog Biochemistry. 38: 14868-14880. PMID 10555969 DOI: 10.1021/Bi9910068  0.361
1999 Chen LL, Whitty A, Lobb RR, Adams SP, Pepinsky RB. Multiple activation states of integrin α4β1 detected through their different affinities for a small molecule ligand Journal of Biological Chemistry. 274: 13167-13175. PMID 10224072 DOI: 10.1074/Jbc.274.19.13167  0.437
1999 Taylor FR, Bixler SA, Budman JI, Wen D, Karpusas M, Ryan ST, Jaworski GJ, Safari-Fard A, Pollard S, Whitty A. Induced fit activation mechanism of the exceptionally specific serine protease, complement factor D. Biochemistry. 38: 2849-59. PMID 10052957 DOI: 10.1021/Bi982140F  0.355
1999 Whitty A, Borysenko CW. Small molecule cytokine mimetics Chemistry and Biology. 6. DOI: 10.1016/S1074-5521(99)80034-9  0.31
1998 Nash P, Whitty A, Handwerker J, Macen J, McFadden G. Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1 Journal of Biological Chemistry. 273: 20982-20991. PMID 9694848 DOI: 10.1074/Jbc.273.33.20982  0.328
1997 Sanicola M, Hession C, Worley D, Carmillo P, Ehrenfels C, Walus L, Robinson S, Jaworski G, Wei H, Tizard R, Whitty A, Pepinsky RB, Cate RL. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins Proceedings of the National Academy of Sciences of the United States of America. 94: 6238-6243. PMID 9177201 DOI: 10.1073/Pnas.94.12.6238  0.415
1995 Lobb RR, Antognetti G, Pepinsky RB, Burkly LC, Leone DR, Whitty A. A direct binding assay for the vascular cell adhesion molecule-1 (VCAM1) interaction with α4 integrins Cell Communication and Adhesion. 3: 385-397. PMID 8640376 DOI: 10.3109/15419069509081293  0.401
1995 Whitty A, Fierke CA, Jencks WP. Role of binding energy with coenzyme A in catalysis by 3-oxoacid coenzyme A transferase. Biochemistry. 34: 11678-89. PMID 7547900 DOI: 10.1021/Bi00037A005  0.683
Show low-probability matches.